Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Advancing hepatitis B virus entry inhibitors.

Literature DB >> 27965159

Advancing hepatitis B virus entry inhibitors.

Eloi R Verrier¹, Catherine Schuster¹, Thomas F Baumert².

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2016 PMID： 27965159 PMCID： PMC5362280 DOI： 10.1016/j.jhep.2016.11.028

Source DB: PubMed Journal: J Hepatol ISSN： 0168-8278 Impact factor: 30.083

× No keyword cloud information.

19 in total

Review 1. Hepatitis B virus infection.

Authors: Christian Trépo; Henry L Y Chan; Anna Lok
Journal: Lancet Date: 2014-06-18 Impact factor: 79.321

Review 2. HBV cure: why, how, when?

Authors: Massimo Levrero; Barbara Testoni; Fabien Zoulim
Journal: Curr Opin Virol Date: 2016-07-19 Impact factor: 7.090

Review 3. The hepatitis B virus receptor.

Authors: Wenhui Li
Journal: Annu Rev Cell Dev Biol Date: 2015-10-02 Impact factor: 13.827

4. Sodium taurocholate cotransporting polypeptide (SLC10A1) deficiency: conjugated hypercholanemia without a clear clinical phenotype.

Authors: Frédéric M Vaz; Coen C Paulusma; Hidde Huidekoper; Minke de Ru; Cynthia Lim; Janet Koster; Kam Ho-Mok; Albert H Bootsma; Albert K Groen; Frank G Schaap; Ronald P J Oude Elferink; Hans R Waterham; Ronald J A Wanders
Journal: Hepatology Date: 2014-08-25 Impact factor: 17.425

5. A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide.

Authors: Manabu Kaneko; Koichi Watashi; Shinji Kamisuki; Hiroki Matsunaga; Masashi Iwamoto; Fumihiro Kawai; Hirofumi Ohashi; Senko Tsukuda; Satomi Shimura; Ryosuke Suzuki; Hideki Aizaki; Masaya Sugiyama; Sam-Yong Park; Takayoshi Ito; Naoko Ohtani; Fumio Sugawara; Yasuhito Tanaka; Masashi Mizokami; Camille Sureau; Takaji Wakita
Journal: J Virol Date: 2015-09-16 Impact factor: 5.103

Review 6. Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure.

Authors: Mirjam B Zeisel; Julie Lucifora; William S Mason; Camille Sureau; Jürgen Beck; Massimo Levrero; Michael Kann; Percy A Knolle; Monsef Benkirane; David Durantel; Marie-Louise Michel; Brigitte Autran; François-Loïc Cosset; Hélène Strick-Marchand; Christian Trépo; Jia-Horng Kao; Fabrice Carrat; Karine Lacombe; Raymond F Schinazi; Françoise Barré-Sinoussi; Jean-François Delfraissy; Fabien Zoulim
Journal: Gut Date: 2015-02-10 Impact factor: 23.059

7. Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study.

Authors: Pavel Bogomolov; Alexander Alexandrov; Natalia Voronkova; Maria Macievich; Ksenia Kokina; Maria Petrachenkova; Thorsten Lehr; Florian A Lempp; Heiner Wedemeyer; Mathias Haag; Matthias Schwab; Walter E Haefeli; Antje Blank; Stephan Urban
Journal: J Hepatol Date: 2016-04-27 Impact factor: 25.083

Advancing hepatitis B virus entry inhibitors.

Review 1. Hepatitis B virus infection.

Review 2. HBV cure: why, how, when?

Review 3. The hepatitis B virus receptor.

4. Sodium taurocholate cotransporting polypeptide (SLC10A1) deficiency: conjugated hypercholanemia without a clear clinical phenotype.

5. A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide.

Review 6. Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure.

7. Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study.

Review 8. Fresh approaches to anti-infective therapies.

Review 9. The solute carrier family 10 (SLC10): beyond bile acid transport.

Review 10. New perspectives for preventing hepatitis C virus liver graft infection.

1. Rhein inhibits Chlamydia trachomatis infection by regulating pathogen-host cell.

2. Epigallocatechin gallate inhibits hepatitis B virus infection in human liver chimeric mice.